The Ischemic Stroke drug pipeline is advancing with novel thrombolytics, neuroprotective agents, and regenerative therapies to improve recovery outcomes and reduce stroke-related disabilities. https://www.expertmarketresearch.com/clinical-trials/ischemic-stroke-drug-pipeline-insight